Post-endoscopic retrograde cholangiopancreatography pancreatitis: Overview and pathophysiology

被引:0
|
作者
Koutroumpakis, Efstratios I. [1 ]
Papachristou, Georgios I. [1 ,2 ]
机构
[1] Univ Pittsburgh, Presbyterian Univ Hosp, Med Ctr, Div Gastroenterol Hepatol & Nutr, M2,C Wing,200 Lothrop St, Pittsburgh, PA 15213 USA
[2] Vet Affairs Pittsburgh Hlth Syst, Div Gastroenterol & Hepatol, Pittsburgh, PA 15213 USA
关键词
Acutepancreatitis; ERCP; Definition; Severity; Pathogenesis; Mechanisms;
D O I
10.1016/j.tgie.2014.09.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Endoscopic retrograde cholangiopancreatography is a widely used therapeutic endoscopic procedure with small risk of complications. The most common and dreadful complication is post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP). Concerning the definition of PEP itself and classification of its severity, there is still some ambiguity. The most commonly used definition is the one proposed in the 1991 consensus, although there are indications that the current clinical definition and the 2 new severity classifications, namely the revised Atlanta classification and the determinant-based classification are more accurate in diagnosing and classifying PEP, respectively. Pathogenesiswise, although the inflammatory cascade after trypsin activation is the same regardless of the etiology and has been studied intensively over the last few years, the data on the initial pancreatic insult in PEP are scarce. Several factors have been proposed as the first trigger to include mechanical trauma or thermal injury or both to the papilla, high hydrostatic pressure in the pancreatic duct, contrast-induced injury, and contamination of the pancreatic duct by intestinal flora. The authors? impression is that the onset of PEP is likely multifactorial, a combination of the aforementioned mechanisms in an already susceptible subject carrying, yet to be identified, environmental or genetic risks or both. Trypsin is not only the main digestive, but also the regulatory enzyme that activates the rest of the zymogens. Intrapancreatic activation of trypsinogen results in pancreatic autodigestion and a subsequent burst of cytokine release that may progress to either a local or a systemic inflammatory response. Published by Elsevier Inc.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [21] Pancreatic Stents for prevention of post-endoscopic retrograde Cholangiopancreatography pancreatitis
    Freeman, Martin L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (11) : 1354 - 1365
  • [22] Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis
    Khoshbaten, Manouchehr
    Khorram, Homayoun
    Madad, Leili
    Ardakani, Mohammad Javad Ehsani
    Farzin, Haleh
    Zali, Mohammmad Reza
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (07) : E11 - E16
  • [23] preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta analysis
    Dan, Jiang
    Yu, Laiming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 888 - 888
  • [24] Best practices for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Weissman, Simcha
    Ahmed, Mohamed
    Baniqued, Matthew R.
    Ehrlich, Dean
    Tabibian, James H.
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2021, 13 (06): : 161 - 169
  • [25] Race as a Risk Factor for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Rogers, Hayley K.
    Haddad, James
    Liu, Po-Hong
    Chang, Patrick
    Phan, Jennifer
    Tielleman, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1143 - S1143
  • [26] Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Medications and Techniques
    Wang, Andrew Y.
    Strand, Daniel S.
    Shami, Vanessa M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1521 - +
  • [27] Indomethacin to Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: When and How?
    George, John
    Saluja, Ashok K.
    Barkin, Jamie S.
    GASTROENTEROLOGY, 2017, 152 (01) : 306 - 307
  • [28] No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
    Ishiwatari, Hirotoshi
    Urata, Takahiro
    Yasuda, Ichiro
    Matsusaki, Shimpei
    Hisai, Hiroyuki
    Kawakami, Hiroshi
    Ono, Michihiro
    Iwashita, Takuji
    Doi, Shinpei
    Kawakubo, Kazumichi
    Hayashi, Tsuyoshi
    Sonoda, Tomoko
    Sakamoto, Naoya
    Kato, Junji
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) : 3292 - 3301
  • [29] Pharmacological Prophylaxis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP)
    Gochanour, Eric
    Abdelfatah, Mohamed M.
    Jampala, Nannaya
    Movahed, Hossein
    Ali, Eslam G.
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB246 - AB246
  • [30] Statin consumption and risk of post-endoscopic retrograde cholangiopancreatography pancreatitis
    Martinez-Moneo, Emma
    Cardenas-Jaen, Karina
    Fernandez-Laso, Ana B.
    Millastre-Bocos, Judith
    Torralba-Gallego, Ainara
    Martin-Arriero, Silvia
    Alfaro-Almajano, Enrique
    Garcia-Rayado, Guillermo
    de-Madaria, Enrique
    PANCREATOLOGY, 2020, 20 (05) : 801 - 805